期刊文献+

非清髓性骨髓移植对移植物抗宿主病的影响

Study on nonmyeloablative conditioning regiment effect on graft-versus-host disease in allogeneic bone marrow transplantation
下载PDF
导出
摘要 目的 探讨非清髓性预处理方案对大鼠异基因骨髓移值模型移植物抗宿主病(GVHD)的影响。方法 Wistar大鼠为供鼠,SD大鼠为受鼠,受鼠分两组,分别予以不同的预处理方案,A组受鼠自移植前4-1d,腹腔注射氟达拉宾(1mg/kg),移植前4h接受2Gy的全身照射;B组受鼠仅在移植当天分别接受6Gy的全身照射。各实验组受鼠均在移植当天经尾静脉输注供鼠骨髓细胞3.8×107;对照组大鼠输注等量的生理盐水,观察各组大鼠GVHD反应。结果 移植前接受氟达拉宾和2Gy全身照射预处理的大鼠生存期较长,且GVHD临床和病理评分也较低。结论 非清髓性骨髓移植预处理方案可有效预防GVHD,拓宽临床进行异基因骨髓移植的适用范围。 Objective To explore the effect of nonmyeloablative conditioning regiment in graft-versus-host disease ( GVHD) after bone marrow transplantation( BMT) in rat models. Methods SD rats were transplanted with Wistar rats in the allogeneic bone marrow transplantation model. SD rats were divided into 2 groups: group A were conditioned with fludarabine for 4 d at a dose of 1 mg/kg on days 4 , 3 , 2 , 1 prior to transplantation, and received total body irradiation (TBI) 2 Gy 4 h prior to BMT and group B were exposed to a dose of 6 Gy TBI on the same time. All the recipient rats of the test group were injected with donor bone marrow cells at a dose of 3. 8 × 10 bone marrow cells per mouse through the tail vein. Rats in the control group were injected with the same volume of saline. Afterwards we observed the GVHD of both groups. Results The survival time of rats which received fludarabine and 2 Gy TBI were longer, and the severity of GVHD was lower. Conclusion Nonmyeloablative allogeneic bone marrow transplantation could effectively prevent GVHD. This conditioning regimen could broaden the application of allogeneic bone marrow transplantation.
出处 《上海第二医科大学学报》 CSCD 2004年第5期337-339,共3页 Acta Universitatis Medicinalis Secondae Shanghai
基金 上海血液学研究所胡应洲基金资助项目
关键词 非清髓性骨髓移植 移植物抗宿主病 实验方法 指标观察 预处理 大鼠 bone marrow transplantation nonmyeloablative graft-versus-host disease
  • 相关文献

参考文献8

  • 1Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation:I. the roles of minor H antigens and endotoxin [J]. Blood, 1996,88:3 230-3 239.
  • 2Bryson JS, Jennings CD, Lowery DM, et al. Rejection of an MHC class 11 negative tumor following induction of murine syngeneic graftversus-host disease [J]. Bone Marrow Transplant, 1999, 23: 363-372.
  • 3Khouri IF, Keating M, Korbling M, etal. Transplant-lite: induction of graft-versus-malignancy using fludarabine-lased nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies[J]. J Clin Oncol, 19
  • 4Nagler A, Ackerstein A, Kapelushnik J, et al. Donor lymphocyte infusion post-non-myeloablative allogenieic peripheral blood stem cell transplantation for chronic granulomatous disease [J]. Bone Marrow Transplantation, 1999, 24: 339 - 342.
  • 5Champlin R, Khouri I, Kornblau S,et al. Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy [J]. Curr Opin Oncol, 1999, 11(2): 87.
  • 6罗晖,胡盛惠,杨平地.清除小鼠特异性活化淋巴细胞预防急性移植物抗宿主病的研究[J].中华血液学杂志,1995,16(10):521-523. 被引量:15
  • 7杜冰,李德鹏,徐开林,潘秀英.非清除性异基因骨髓移植后输注供者淋巴细胞治疗白血病的实验研究[J].中华血液学杂志,2001,22(8):403-404. 被引量:14
  • 8杜欣.GVHD的发生机制及其防治措施[J].实用医学杂志,2000,16(1):7-8. 被引量:4

二级参考文献1

  • 1Weiss L,Bone Marrow Transplant,1999年,23卷,1139页

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部